Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-02 Sale |
2022-08-02 5:40 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
2,000 | $11.97 | $23,940 | 540,257 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-06 4:16 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
2,000 | $11.44 | $22,880 | 542,257 (Direct) |
View |
| 2022-06-21 Sale |
2022-06-22 4:47 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
2,000 | $11.18 | $22,360 | 544,257 (Direct) |
View |
| 2022-05-19 Sale |
2022-05-19 5:40 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
11,500 | $7.3993 | $85,092 | 546,257 (Direct) |
View |
| 2022-03-15 Sale |
2022-03-17 5:59 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
5,169 | $7.709 | $39,848 | 320,119 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-04 5:55 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
11,507 | $24.35 | $280,185 | 323,928 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 5:01 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
2,798 | $38.05 | $106,471 | 110,035 (Direct) |
View |
| 2020-10-07 Sale |
2020-10-08 5:10 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
16,538 | $39.4 | $651,515 | 111,677 (Direct) |
View |
| 2020-10-01 Sale |
2020-10-02 4:40 pm |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
9,752 | $36.37 | $354,662 | 128,215 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-03 Exercise |
2025-04-07 4:48 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
5,391 | $0 | 55,960 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:06 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
19,523 | $0 | 101,385 (Direct) |
View |
| 2025-03-12 Option Award |
2025-03-14 5:14 pm |
N/A 2035-03-12 |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
86,817 | $0 | 86,817 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:17 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
58,950 | $0 | 0 (Direct) |
View |
| 2024-12-30 Exercise |
2025-01-02 4:13 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
21,000 | $0 | 96,834 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:12 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 5:47 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
5,391 | $0 | 39,705 (Direct) |
View |
| 2024-04-03 Exercise |
2024-04-05 5:47 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
5,391 | $15.9 | 39,705 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 9:43 pm |
N/A 2034-04-01 |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
198,233 | $0 | 198,233 (Direct) |
View |
| 2023-12-29 Exercise |
2024-01-03 7:26 pm |
N/A N/A |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
42,000 | $0 | 106,637 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 4:14 pm |
N/A 2033-04-30 |
Poseida Therapeutics Inc. | PSTX | Amado Rafael Director |
94,500 | $0 | 94,500 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 4:05 pm |
N/A 2033-04-03 |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
134,781 | $0 | 134,781 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-03 4:10 pm |
N/A 2032-12-30 |
Zai Lab Ltd | ZLAB | Amado Rafael See Remarks |
309,700 | $0 | 309,700 (Direct) |
View |
| 2022-10-07 Tax Withholding |
2022-10-11 4:35 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D |
8,464 | $11.83 | 541,946 (Direct) |
View |
| 2022-10-07 Option Award |
2022-10-11 4:35 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D |
19,120 | $0 | 541,946 (Direct) |
View |
| 2022-10-03 Tax Withholding |
2022-10-05 4:02 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D |
8,968 | $11.06 | 531,290 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 5:52 pm |
N/A 2032-03-23 |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
605,947 | $0 | 926,066 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-20 5:22 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
200,534 | $0 | 335,435 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 4:47 pm |
N/A 2031-03-26 |
Allogene Therapeutics Inc. | ALLO | Amado Rafael EVP of R&D and CMO |
117,231 | $0 | 227,266 (Direct) |
View |